CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Trimurthi Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Trimurthi Ltd
4-4-231/A,B,C, Inderbagh, Sultan Bazar
Phone: +91 4024757370p:+91 4024757370 HYDERABAD, 500027  India Ticker: 536565536565
Business Summary
Trimurthi Limited is an India-based holding company. The Company is engaged in pharmaceutical distribution and retail pharmacy. The Company’s segments include Pharma Business, Financial Services, Investments, Foods and Trading in Shares. The Company’s services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include ULCIZOL, OXYMIN, Volivia Gold, Conplus, Oriflox, Treb-DSR, ACLO-P, LAMITAB and others. The Company has its pharmacy retail Outlet in Himayath Nagar, Hyderabad and Inderbagh, Sultan Bazar, Hyderabad. It has its operations in the state of West Bengal and has its presence in the Eastern part of India. Trimurthi Pharmaceuticals (India) Private Limited is the Company’s subsidiary.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20233/31/2023Yes----

Industries
SIC Code Description
6211 Security brokers, dealers, and flotation companies
6289 Services allied with the exchange of securities or commodities
6799 Investors, not elsewhere classified
5912 Drug stores and proprietary stores
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Managing Director Arun K.Bhangadia 58 1/1/2022 5/4/2005
Chief Financial Officer VaniManda 9/4/2014 9/4/2014
Compliance Officer, Company Secretary NishitaKalantri 4/1/2019 4/1/2019
4 additional Officers and Directors records available in full report.

Business Names
Business Name
536565
Trimurthi Drugs & Pharmaceuticals Ltd
Trimurthi Drugs and Pharmaceuticals Ltd

General Information
Outstanding Shares: 8,100,000 (As of 9/30/2023)
Shareholders: 2,762
Stock Exchange: BOM
Fax Number: +91 4024757370


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024